Elessawy M, Mabrouk M, Heilmann T, Weigel M, Zidan M, Abu-Sheasha G, Farrokh
A, Bauerschlag D, Maass N, Ibrahim M, Kamel D (2021) Evaluation of Laparoscopy
Virtual Reality Training on the Improvement of Trainees' Surgical Skills. Medicina
(Kaunas) 57:130.

Heilmann T, Rumpf AL, Roscher M, Tietgen M, Will O, Gerle M, Damm T, Borzikowsky C, Maass N, Glüer CC, Tiwari S, Trauzold A, Schem C (2020) Dasatinib prevents skeletal metastasis of osteotropic MDA-MB-231 cells in a Xenograft mouse model. Arch Gynecol Obstet. 301:1493-1502.

Heilmann T, Vondung F, Borzikowsky C, Krüger S, Elessawy M, Alkatout I, Wenners
A, Bauer M, Klapper W, Röcken C, Maass N, Schem C, Trauzold A (2020) Cytoplasmic levels of High mobility group A2 (HMGA2) determine survival prognoses in breast cancer patients. Int J Biol Marker 35:20-28.

Farrokh A, Maass N, Treu L, Heilmann T, Schäfer FK (2019) Accuracy of tumor size
measurement: comparison of B-mode ultrasound, strain elastography, and 2D and 3D shear wave elastography with histopathological lesion size. Acta Radiol 60:451-458.

Heilmann T, Pfisterer J, Hempel AM, Saß S, Hedderich J, Pujade-Lauraine E, Harter
P, du Bois A, Hilpert F (2019) Early treatment modifications improve chemotherapy
adherence in ovarian cancer patients ≥70 years. Gynecol Oncol 153:616-624.

Heilmann T, Vondung F, Borzikowsky C, Szymczak S, Krüger S, Alkatout I, Wenners
A, Bauer M, Klapper W, Röcken C, Maass N, von Karstedt S, Schem C, Trauzold A
(2019) Heterogeneous intracellular TRAIL-receptor distribution predicts poor outcome
in breast cancer patients. J Mol Med 97:1155-1167.

Elessawy M, Wewer A, Guenther V, Heilmann T, Eckmann-Scholz C, Schem C,
Maass N, Noe KG, Mettler L, Alkatout I (2017) Validation of psychomotor tasks by
Simbionix LAP Mentor simulator and identifying the target group. Minim Invasiv Ther
22:1-7.

Schem C, Tower RJ, Kneissl P, Rambow AC, Campbell GM, Desel C, Damm T,
Heilmann T, Fuchs S, Zuhayra M, Trauzold A, Glüer CC, Schott S, Tiwari S (2017)
Pharmacologically Inactive Bisphosphonates as an Alternative Strategy for Targeting
Osteoclasts: In Vivo Assessment of 5-Fluorodeoxyuridine-Alendronate in a Preclinical
Model of Breast Cancer Bone Metastases. J Bone Miner Res 32:536-548.

Schmidt T, Heilmann T, Savelsberg L, Maass N, Weisser B, Eckmann-Scholz C
(2017) Physical Exercise During Pregnancy - How Active Are Pregnant Women in
Germany and How Well Informed? Geburtsh Frauenheilk 77:508-515.

Heilmann T, Dittmann L, van Mackelenbergh M, Mundhenke C, Weimer J, Arnold N,
Maass N, Schem C (2016) Head-to-head comparison of the impact of Aurora A, Aurora B, Repp86, CDK1, CDK2 and Ki67 expression in two of the most relevant
gynaecological tumor entities. Arch Gynecol Obstet 294:813-823.

van Mackelenbergh MT, Lindner CM, Heilmann T, Alkatout I, Elessawy M, Mundhenke C, Maass N, Schem C (2016) Impact of Histopathological Factors, Patient History and Therapeutic Variables on Recurrence-free Survival after Ductal Carcinoma in Situ: 8-Year Follow-up and Questionnaire Survey. Geburtsh Frauenheilk 76:46-52.

Fritsche H, Heilmann T, Tower RJ, Hauser C, von Au A, El-Sheikh D, Campbell
GM, Alp G, Schewe D, Hübner S, Tiwari S, Kownatzki D, Boretius S, Adam D, Jonat
W, Becker T, Glüer CC, Zöller M, Kalthoff H, Schem C, Trauzold A (2015) TRAIL-R2
promotes skeletal metastasis in a breast cancer xenograft mouse model. Oncotarget
20:9502-9516.

Heilmann T, Mathiak M, Hofmann J, Mundhenke C, van Mackelenbergh M, Alkatout
I, Wenners A, Eckmann-Scholz C, Schem C (2013) Intra-operative use of one-step
nucleic acid amplification (OSNA) for detection of the tumor load of sentinel lymphnodes in breast cancer patients. J Cancer Res Clin 139:1649-1655.

Heilmann T, Maass N (2021) Nachsorge nach Mammakarzinomerkrankung. Der
Gynäkologe 54:77–82.

chem C, Maass N, Elessawy M, van Mackelenbergh MT, Heilmann T (2017) New
substances in breast cancer treatment: Which options suit which patients? Der
Gynäkologe 50:1-7.

Schem C, Wenners A, van Mackelenbergh MT, Heilmann T, Mathiak M, Jonat W,
Mundhenke C (2013) Prädiktion beim Mammakarzinom. Der Gynäkologe 46:377-381.

Farahmandi S, Elessawy M, Bauerschlag DO, Pecks U, Abdullazade S, Beckmann JH, Heilmann T, Rumpf AL, Maass N, Jansen P, Winkler V (2021) Mucinous Cystic Neoplasm of Pancreas in a Pregnant Woman Presenting with Severe Anemia and Gastric Bleeding: Case Report and Review of the Literature. Healthcare (Basel) 9:540.

Rumpf AL, Mathiak M, Schäfer FK, Caliebe A, Farrokh A, Elessawy M, Bauerschlag
DO, Maass N, van Mackelenbergh M, Heilmann T (2020) A giant mammary
hamartoma in a young breast cancer patient. Breast Care 16:85-88.

Heilmann T, Leuschner I, Hilpert F, Kümper C, Strauss A, Mundhenke C, Jonat W,
Bauer M (2012) Diagnosis and management of an unilateral giant fibroadenoma of the breast in pregnancy. Arch Gynecol Obstet 285:235-237.

Heilmann T (2020) Leitsituation Nachsorge des Mammakarzinoms. In Felberbaum
R.E. (ed.), Facharztprüfung Gynäkologie und Geburtshilfe (Edition 3), Section 4
Gynäkologische Onkologie und Senologie. Elsevier GmbH Deutschland, pp. 277-280.

Heilmann T (2013) Geburtshilfliche Operationen. In Strauss A (ed.),
Behandlungspfade in Gynäkologie und Geburtshilfe, Section 1 Geburtshilfe und
Pränatalmedizin. Springer-Verlag Berlin Heidelberg, pp. 145-151.